Sertoli-Leydig cell tumor
Showing 1 - 25 of >10,000
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition
Recruiting
- Pleuropulmonary Blastoma
- +4 more
-
Bethesda, Maryland
- +1 more
Dec 29, 2022
Elucidating Genetic Basis of Pleuropulmonary Blastoma Familial
Active, not recruiting
- Pleuropulmonary Blastoma
- +9 more
-
Washington, District of ColumbiaChildren's National Medical Center
Mar 9, 2022
International PPB/DICER1 Registry
Recruiting
- Pleuropulmonary Blastoma
- +14 more
-
Minneapolis, MinnesotaChildren's Minnesota
Aug 16, 2022
Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor Trial in United States (biological,
Active, not recruiting
- Ovarian Granulosa Cell Tumor
- +6 more
- Bleomycin Sulfate
- +5 more
-
Anchorage, Alaska
- +218 more
Dec 30, 2021
Malignant Ovarian Epithelial Tumor, Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma Trial in United States (Bevacizumab,
Completed
- Malignant Ovarian Epithelial Tumor
- +7 more
- Bevacizumab
- Laboratory Biomarker Analysis
-
Los Angeles, California
- +35 more
Jul 19, 2019
Adult Type Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor Trial in Japan, United
Completed
- Adult Type Ovarian Granulosa Cell Tumor
- +4 more
-
Birmingham, Alabama
- +97 more
Feb 18, 2020
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma Trial in Puerto Rico, United States
Recruiting
- Bladder Adenocarcinoma
- +45 more
- Cabozantinib S-malate
- +2 more
-
Birmingham, Alabama
- +563 more
Aug 24, 2022
Spermatogenesis and Semen Disorders Trial in Hô` Chi´ Minh (FPT-20)
Completed
- Spermatogenesis and Semen Disorders
-
Hồ Chí Minh, Ho Chi Minh City, VietnamSaigon Biopharma Company Limited
May 26, 2022
Urothelial Cancer and Rare Genitourinary Tract Malignancies
Recruiting
- Urothelial Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Aflatoxin Metabolites Concentration in Follicular Fluid on
Not yet recruiting
- Aflatoxin Poisoning
- (no location specified)
Jan 31, 2023
RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)
Recruiting
- Cervical
-
Wuxi, Jiangsu, ChinaWuxi People's Hospital
Jul 3, 2023
LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational
Not yet recruiting
- Relapsed Non-Hodgkin Lymphoma
- (no location specified)
Sep 19, 2023
Serum Adrenal Androgens Among Prepubertal and Pubertal Boys With
Not yet recruiting
- Autism Spectrum Disorder
- serum total testosterone, serum androsterone, serum androstenedione and serum dehydroepiandrosterone sulfate
- +3 more
-
Sohag, EgyptSohag University Hospital
Apr 12, 2023
Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
- +2 more
-
Marlborough, MassachusettsPhio Pharmaceuticals Corp.
Aug 25, 2023
Stage T3 Squamous Cell Carcinomas of the Scalp
Active, not recruiting
- Squamous Cell Carcinoma
- +2 more
-
Maastricht, NetherlandsEllen Oyen
Aug 3, 2023
Autologous Natural Killer Cell Activity in Primary Cancer Cell
Recruiting
- Sarcoma
-
Santa Monica, CaliforniaSarcoma Oncology Research Center
May 19, 2023
Melanoma Trial (pembrolizumab, )
Active, not recruiting
- Melanoma
- pembrolizumab
- placebo
- (no location specified)
Aug 18, 2022
Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Amivantamab
- +3 more
- (no location specified)
Oct 30, 2023
Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Rochester (Durvalumab, Radiation Therapy)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Stage III Lung Cancer AJCC v8
- Durvalumab
- Radiation Therapy
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Pediatric Germ Cell Tumor Trial in Seoul (TIP treatment (paclitaxel/ifosfamide/cisplatin))
Recruiting
- Pediatric Germ Cell Tumor
- TIP treatment (paclitaxel/ifosfamide/cisplatin)
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jul 8, 2022
Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)
Recruiting
- Metastatic Pancreatic Cancer
- MesoPher
- Mitazalimab
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Dec 6, 2022
Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified
Recruiting
- Endometrial Cancer
- +8 more
- Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
-
Orlando, Florida
- +21 more
Feb 2, 2023
Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell
Not yet recruiting
- Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +5 more
- Avelumab
- +6 more
- (no location specified)
Jul 13, 2023
Infiltrating Duct Carcinoma of the Breast
Not yet recruiting
- Invasive Breast Cancer
- (no location specified)
Jan 28, 2023
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +24 more
- 18F-Fluoromisonidazole
- +4 more
-
La Jolla, California
- +15 more
Jan 3, 2023